Boston Scientific BSX Difference between equity method investment carrying value and book value

Difference between equity method investment carrying value and book value at other companies

DowDOW

$138M—

MPLXMPLX

$283M-2.7%

RB GlobalRBA

$5.8M—

Phillips 66PSX

$800M-10.1%

AlbemarleALB

$894.97M+52.8%

Simon Property GroupSPG

$3.54M+11.8%

Other financials

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.4%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$67.32B-37.5%

P/E18.9×-34.3×

P/S3.3×-2.9×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's difference between equity method investment carrying value and book value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's difference between equity method investment carrying value and book value?: Boston Scientific (BSX) reported difference between equity method investment carrying value and book value of $334M in Q1 2026.
How has Boston Scientific's difference between equity method investment carrying value and book value changed year-over-year?: Boston Scientific's difference between equity method investment carrying value and book value decreased by 10.7% year-over-year, from $374M to $334M.